NICOX (EPA:COX) | WebDisclosure

Basculer en Français

10948	Companies
239368	Keywords
168210	Articles
128743	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year 3 months ago

Nicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representative
Nicox SA announces Ordinary and Extraordinary Shareholders' Meeting on June 27, 2025, appoints ad hoc representative. Details on agenda, proxy voting, and meeting participation

Shareholders' Meeting Proxy Voting Nicox SA Ad Hoc Representative Meeting Participation
PRESS RELEASE

published on 06/06/2025 at 07:30, 1 year 3 months ago

Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025 et désignation d’un mandataire ad hoc
Nicox convoque une Assemblée Générale Ordinaire et Extraordinaire le 27 juin 2025, avec un mandataire ad hoc pour représenter les actionnaires défaillants

Actionnaires Assemblée Générale Ophtalmologie Nicox Mandataire Ad Hoc
BRIEF

published on 05/27/2025 at 07:35, 1 year 3 months ago

Nicox obtient jusqu'à 3 millions d'euros grâce à Kowa pour l'avancée de NCX 470

Phase 3 Nicox Hypertension Oculaire NCX 470 Kowa
BRIEF

published on 05/27/2025 at 07:35, 1 year 3 months ago

Nicox secures up to €3 million from Kowa to advance NCX 470

Ocular Hypertension Phase 3 Nicox NCX 470 Kowa
PRESS RELEASE

published on 05/27/2025 at 07:30, 1 year 3 months ago

Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon
Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025 pour le lancement d'essais cliniques de Phase 3 de NCX 470 au Japon, prolongeant ainsi leur horizon de trésorerie

Essais Cliniques Nicox Horizon De Trésorerie Kowa Paiements D'étapes
BRIEF

published on 05/14/2025 at 07:35, 1 year 3 months ago

Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial

Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
BRIEF

published on 05/14/2025 at 07:35, 1 year 3 months ago

Nicox publie les résultats de l'essai de phase 3b sur le glaucome à Whistler

Nicox NCX 470 Glaucome Whistler Phase 3b Pression Intraoculaire
PRESS RELEASE

published on 05/14/2025 at 07:30, 1 year 3 months ago

Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial
Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial

Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF

published on 04/30/2025 at 07:35, 1 year 4 months ago

Nicox Reports Full Year 2024 Financials

Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
BRIEF

published on 04/30/2025 at 07:35, 1 year 4 months ago

Nicox publie ses résultats financiers pour l'année 2024

Perte Nette Réserves De Trésorerie Résultats Financiers De Nicox Vente De Revenus De VYZULTA Essais NCX 470

Accesswire

Published on 09/09/2026 at 00:35, 4 hours 45 minutes ago

Troubadour Resources Announces Non-Brokered Unit Private Placement and Convertible Debenture Financing
Published on 09/09/2026 at 00:25, 4 hours 55 minutes ago

Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
Published on 09/08/2026 at 23:35, 5 hours 45 minutes ago

The Western Investment Company of Canada Limited Announces Intention to Commence Normal Course Issuer Bid
Published on 09/08/2026 at 22:30, 6 hours 50 minutes ago

Grid Metals Announces Positive Mineralogical Results at Falcon West, Engages SGS Canada for Ore Sorting Test Work, and Announces Investor Relations Agreements
Published on 09/08/2026 at 22:15, 7 hours 5 minutes ago

GameSquare Regains Compliance with Nasdaq's Minimum Bid Price Requirement

View all ACCESSWIRE

EQS Group

Published on 09/08/2026 at 22:50, 6 hours 30 minutes ago

Cataneo Set to Unveil the Future of AI Engagement at IBC2026 in Amsterdam
Published on 09/08/2026 at 22:05, 7 hours 15 minutes ago

oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag
Published on 09/08/2026 at 18:30, 10 hours 50 minutes ago

Avolta extends long-term travel retail contracts across four Mexican airports
Published on 09/08/2026 at 18:30, 10 hours 50 minutes ago

Designated Person Notification
Published on 09/08/2026 at 18:30, 10 hours 50 minutes ago

Designated Person Notification

Les Echos

Published on 09/08/2026 at 17:45, 11 hours 35 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 11 hours 35 minutes ago

Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 17:45, 11 hours 35 minutes ago

Damartex / Résultats de l'exercice 2025-2026
Published on 09/08/2026 at 11:00, 18 hours 20 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 18 hours 20 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL

View all LES ECHOS COMFI WIRE